A Study to Assess the Safety and Efficacy of ADVAGRAF (Tacrolimus Modified Release Formulation) in Kidney Transplant Patients Who Were Treated With PROGRAF
Clinical trial NCT01839929 · COMPLETED
Trial details
- NCT number
- NCT01839929
- Sponsor
- Astellas Pharma Korea, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2013-02-01
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.